The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats
Giulia Costa, Marcello Serra, Nicholas Pintori, M. Casu, Mary T. Zanda, D. Murtas, M. A. de Luca, Nicola Simola, Liana Fattore
Neuropharmacology 2019 DOI: 10.1016/j.neuropharm.2018.10.031 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal experiment Peer reviewed |
|---|---|
| Population | Rats |
| Intervention | Methoxetamine (MXE) |
| Dose | 0.1–0.5 mg/kg, i.p., every other day × 5, and challenge 0.1–0.5 mg/kg i.p. |
| Duration | Every other day for 5 doses, with challenge 7 days later and behavioral testing starting 8 days after challenge |
| Measures | elevated plus maze, spontaneous alternation, novel object recognition, marble burying tests, ultrasonic vocalizations, locomotor activity, dopamine transporter density, tyrosine hydroxylase density, serotonin transporter density |
| Key findings | Repeated administration of methoxetamine induces persistent behavioral abnormalities (increased anxiety, impaired non-spatial memory) and neurotoxicity (dopaminergic and serotonergic damage) in rats. |
Abstract
&NA; Methoxetamine (MXE) is a novel psychoactive substance that can induce several short‐term effects on emotional states and behavior. However, little is known about the persistent emotional and behavioral effects of MXE. Moreover, neurotoxic effects of MXE have been hypothesized, but never demonstrated in vivo. To clarify these issues, rats received repeated treatment with MXE every other day (0.1–0.5 mg/kg, i.p., × 5), and 7 days later they were challenged with MXE (0.1–0.5 mg/kg, i.p.). Behavioral effects of MXE were first evaluated by measuring emission of ultrasonic vocalizations and locomotor activity after each administration. Thereafter, persistent behavioral effects of MXE were evaluated, starting 8 days after challenge, through elevated plus maze, spontaneous alternation, novel object recognition, and marble burying tests. After completion of behavioral analysis, neurotoxic effects of MXE were evaluated by measuring densities of dopamine transporter, tyrosine hydroxylase, and serotonin transporter in various brain regions. Repeated treatment and challenge with MXE affected neither calling behavior nor locomotor activity of rats. Conversely, rats previously treated with MXE exhibited behavioral alterations in the elevated plus maze, marble burying and novel object recognition tests, suggestive of increased anxiety and impaired non‐spatial memory. Noteworthy, the same rats displayed dopaminergic damage in the medial prefrontal cortex, nucleus accumbens, caudate‐putamen, substantia nigra pars compacta, and ventral tegmental area, along with accumbal serotonergic damage. Our findings show for the first time that repeated administration of MXE induces persistent behavioral abnormalities and neurotoxicity in rats, which can help elucidating the risks associated with human MXE consumption. HIGHLIGHTSMethoxetamine is a novel psychoactive substance used as recreational drug.Little is known about the enduring effects of methoxetamine.We evaluated behavior and neurotoxicity in rats repeatedly exposed to methoxetamine.Methoxetamine induced persitent changes in emotional state and non‐spatial memory.Methoxetamine persistently damaged the mesocorticolimbic dopaminergic system.
Citations in the library
Cited by 6
- Stimulant and hallucinogenic novel psychoactive substances; an update Expert Review of Clinical Pharmacology November 2, 2023
- Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie May 1, 2023
- New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT2 receptors in pharmacological and behavioral effects in the rat. Experimental Neurology November 1, 2021
- Characterization of the Neurochemical and Behavioral Effects of the Phenethylamine 2-Cl-4,5-MDMA in Adolescent and Adult Male Rats. The International Journal of Neuropsychopharmacology May 1, 2024
- In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice. Neurotoxicology March 2021
and 1 more in the library
Cites 31
- From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis 2014
- A REVIEW OF KETAMINE ABUSE AND DIVERSION Depression and Anxiety August 1, 2016
- Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants Frontiers in Neuroscience April 19, 2016
- Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research Human Psychopharmacology: Clinical and Experimental July 1, 2013
- The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor. PLoS One June 14, 2016
and 26 more in the library